Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6TM8

Crystal structure of glycoprotein D of Equine Herpesvirus Type 4

Summary for 6TM8
Entry DOI10.2210/pdb6tm8/pdb
DescriptorEnvelope glycoprotein D, GLYCEROL (3 entities in total)
Functional Keywordsglycoprotein d; equine herpesvirus type 4; ehv-4, viral entry, viral protein
Biological sourceEquid alphaherpesvirus 4 (Equine herpesvirus 4)
Total number of polymer chains1
Total formula weight38392.03
Authors
Kremling, V.,Loll, B.,Osterrieder, N.,Wahl, M.,Dahmani, I.,Chiantia, P.,Azab, W. (deposition date: 2019-12-03, release date: 2020-11-11, Last modification date: 2024-02-07)
Primary citationKremling, V.,Loll, B.,Pach, S.,Dahmani, I.,Weise, C.,Wolber, G.,Chiantia, S.,Wahl, M.C.,Osterrieder, N.,Azab, W.
Crystal structures of glycoprotein D of equine alphaherpesviruses reveal potential binding sites to the entry receptor MHC-I.
Front Microbiol, 14:1197120-1197120, 2023
Cited by
PubMed Abstract: Cell entry of most alphaherpesviruses is mediated by the binding of glycoprotein D (gD) to different cell surface receptors. Equine herpesvirus type 1 (EHV-1) and EHV-4 gDs interact with equine major histocompatibility complex I (MHC-I) to initiate entry into equine cells. We have characterized the gD-MHC-I interaction by solving the crystal structures of EHV-1 and EHV-4 gDs (gD1, gD4), performing protein-protein docking simulations, surface plasmon resonance (SPR) analysis, and biological assays. The structures of gD1 and gD4 revealed the existence of a common V-set immunoglobulin-like (IgV-like) core comparable to those of other gD homologs. Molecular modeling yielded plausible binding hypotheses and identified key residues (F213 and D261) that are important for virus binding. Altering the key residues resulted in impaired virus growth in cells, which highlights the important role of these residues in the gD-MHC-I interaction. Taken together, our results add to our understanding of the initial herpesvirus-cell interactions and will contribute to the targeted design of antiviral drugs and vaccine development.
PubMed: 37250020
DOI: 10.3389/fmicb.2023.1197120
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.9 Å)
Structure validation

226707

數據於2024-10-30公開中

PDB statisticsPDBj update infoContact PDBjnumon